Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Nuvation Bio Inc. (NUVB) had Return on Tangible Equity of -16.36% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$4.83M |
|
$-59.01M |
|
$2.58M |
|
$2.26M |
|
$68.42M |
|
$-63.59M |
|
$4.58M |
|
$-59.01M |
|
$-58.97M |
|
$-59.01M |
|
$-59.01M |
|
$-59.01M |
|
$-58.97M |
|
$-63.59M |
|
$-63.22M |
|
340.75M |
|
340.75M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$623.21M |
|
$0.61M |
|
$24.02M |
|
$647.23M |
|
$66.36M |
|
$46.97M |
|
$207.96M |
|
$274.32M |
|
$372.91M |
|
$360.76M |
|
$372.91M |
|
342.23M |
|
| Cash Flow Statement Financials | |
$-90.81M |
|
$109.06M |
|
$193.97M |
|
$35.72M |
|
$247.97M |
|
$212.25M |
|
$19.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.39 |
|
-- |
|
-- |
|
0.11 |
|
0.14 |
|
46.70% |
|
-1315.72% |
|
-1315.72% |
|
-- |
|
-1220.92% |
|
-1220.92% |
|
$-91.06M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
4.67 |
|
0.72 |
|
124.34 |
|
-15.82% |
|
|
Return on Tangible Equity |
-16.36% |
-9.12% |
|
-14.05% |
|
$1.09 |
|
$-0.27 |
|
$-0.27 |
|